Loading
3 insiders bought €64k of shares over the last 90 days, the latest filed 06 Oct 2026.
Cluster: 3 buyers in 30 daysGG1: what insiders have been doing
This page follows insider dealings at GG1 as filed with ASX, a company from the Chemicals sector. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 3 insiders.
Only purchases show up on the open market, 5 purchases in all worth €239k, filed by 3 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 3 senior executives. At €87k, the purchase published on 1 May 2026 by Anthony Bellas is the largest of the period.
Compared with its exchange (2,526 companies, median 3 filings), a count of 5 filings is above the norm. The full history, which starts in 2026, counts 5 purchases against no sales.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (6 October 2026) now reads 11 days.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€239,142
5 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAnthony Bellas2 buys
Edward Boulton2 buys
Quentin Hill1 buy
Since the insiders bought
- -31.2%Entry A$0.13 · Close 14 Oct 2026 A$0.09
- -31.2%Entry A$0.13 · Close 14 Oct 2026 A$0.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.09
Analyst consensus
Income statement
EBITDA-A$114.6k
Net income-A$105.7k0.0% margin
Valuation
P/Book0.6x
Balance sheet & cash
Market capA$6.1M
Free Cash Flow-A$479k
Debt / Equity1%
Profitability & ownership
ROE-13.6%
ROA-6.7%
% insiders52.9%
% institutions0.0%
Last declaration on 6 October 2026
Declarations5 total
300,000 shares@ A$0.100.34% mcap17.5% of flowShareASXISIN AU0000408783ASX:2924-03145428-2A1702493
Canonical exit: 5 Jan 2027 (T+90)
300,000 shares@ A$0.16670.56% mcap26.2% of flowShareASXISIN AU0000408783ASX:2924-03145427-2A1702492
Canonical exit: 5 Jan 2027 (T+90)
225,000 shares@ A$0.10440.26% mcap100.0% of flowShareASXISIN AU0000408783ASX:2924-03145426-2A1702491
Canonical exit: 5 Jan 2027 (T+90)
750,000 shares@ A$0.19100.0% of flowShareASXASX:2924-03085596-2A1669522
Canonical exit: 30 Jul 2026 (T+90)
750,000 shares@ A$0.19100.0% of flowShareASXASX:2924-03085594-2A1669521
Canonical exit: 30 Jul 2026 (T+90)
5 of 5 declarations
About GG1
GG1 is a company operating in the chemical and materials sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
